BSE: 0 | NSE: | Pharmaceuticals & Drugs |
Data is not available for this company.
No data found
No data found
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
No data to display
Return on Equity has declined versus last 3 years average to %
Standalone | Consolidated | |
---|---|---|
TTM EPS (₹) | - | - |
TTM Sales (₹ Cr.) | - | - |
BVPS (₹.) ⓘ | - | - |
Reserves (₹ Cr.) ⓘ | - | - |
P/BV ⓘ | - | - |
PE ⓘ | - | - |
From the Market | |
---|---|
52 Week Low / High (₹) | - / - |
All Time Low / High (₹) | - / - |
Market Cap (₹ Cr.) | - |
Equity (₹ Cr.) | - |
Face Value (₹) | - |
Industry PE ⓘ | - |
Company Name | CMP(₹) | |||||||
---|---|---|---|---|---|---|---|---|
Sun Pharma Inds. | 1,714.3 | 17.3 (1%) | Large Cap | 48,497 | 47.7 | 20.9 | 35.6 | 5.7 |
Dr. Reddys Lab | 1,149.8 | -2.7 (-0.2%) | Large Cap | 28,011 | 64.4 | 19.6 | 17.9 | 3 |
Cipla | 1,452.7 | 8.2 (0.6%) | Large Cap | 25,774 | 61.8 | 15.6 | 23.4 | 3.9 |
Lupin | 2,009.4 | 53 (2.7%) | Mid Cap | 20,011 | 62.8 | 9.7 | 31.1 | 5.4 |
Zydus Lifesciences | 891.3 | 13.8 (1.6%) | Large Cap | 19,547 | 45.1 | 19.3 | 19.5 | 3.9 |
Glenmark Pharma | 1,516.3 | 7.6 (0.5%) | Mid Cap | 11,813 | -6.2 | -10.2 | - | 4.8 |
Torrent Pharma | 3,209.4 | 27.8 (0.9%) | Large Cap | 10,728 | 55 | 14.8 | 57.8 | 13.5 |
Aurobindo Pharma | 1,158.7 | 23.8 (2.1%) | Mid Cap | 10,646 | 33 | 17.2 | 34.4 | 3.3 |
Alkem Laboratories | 4,836.9 | 3.1 (0.1%) | Mid Cap | 9,748 | 190.9 | 18.1 | 25.3 | 4.6 |
Mankind Pharma | 2,428 | -28.7 (-1.2%) | Mid Cap | 9,265 | 47.4 | 19.6 | 51.8 | 7.1 |